Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aasne K Aarsand

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 12, 2013
How to achieve harmonisation of laboratory testing -The complete pictureAasne K Aarsand, Sverre Sandberg
Clinical Chemistry|February 24, 2009
Familial and sporadic porphyria cutanea tarda: characterization and diagnostic strategiesAasne K Aarsand, Helge Boman, Sverre Sandberg
Clinical Chemistry|April 6, 2006
Estimation and application of biological variation of urinary delta-aminolevulinic acid and porphobilinogen in healthy individuals and in patients with acute intermittent porphyriaAasne K Aarsand, Per Hyltoft Petersen, Sverre Sandberg
Clinical Chemistry|July 3, 2019
A Bayesian Approach to Biological Variation AnalysisThomas Røraas, Sverre Sandberg, Aasne K Aarsand, et al.
BMC Health Services Research|July 5, 2019
Self-efficacy and self-management strategies in acute intermittent porphyriaMarte H Hammersland, Aasne K Aarsand, Sverre Sandberg, et al.
Critical Reviews in Clinical Laboratory Sciences|May 17, 2022
Personalized reference intervals: from theory to practiceAbdurrahman Coskun, Sverre Sandberg, Ibrahim Unsal, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 28, 2024
Practical recommendations for biochemical and genetic diagnosis of the porphyriasAasne K Aarsand, Jordi To-Figueras, Sharon Whatley, et al.
Health and Quality of Life Outcomes|April 2, 2020
Health-related quality of life in porphyria cutanea tarda: a cross-sectional registry based studyJanice Andersen, Janne Thomsen, Åshild Rostad Enes, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|December 8, 2022
Frequency of JAK2V617F, MPL and CALR driver mutations and associated clinical characteristics in a Norwegian patient cohort with myeloproliferative neoplasmsSusanne Lilleskare, Marta Vorland, Anh Khoi Vo, et al.
Clinical Chemistry|August 26, 2024
Reference Intervals Revisited: A Novel Model for Population-Based Reference Intervals, Using a Small Sample Size and Biological Variation DataAbdurrahman Coşkun, Sverre Sandberg, Ibrahim Unsal, et al.
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 12, 2013
How to achieve harmonisation of laboratory testing -The complete pictureAasne K Aarsand, Sverre Sandberg
Clinical Chemistry|February 24, 2009
Familial and sporadic porphyria cutanea tarda: characterization and diagnostic strategiesAasne K Aarsand, Helge Boman, Sverre Sandberg
Clinical Chemistry|April 6, 2006
Estimation and application of biological variation of urinary delta-aminolevulinic acid and porphobilinogen in healthy individuals and in patients with acute intermittent porphyriaAasne K Aarsand, Per Hyltoft Petersen, Sverre Sandberg
Clinical Chemistry|July 3, 2019
A Bayesian Approach to Biological Variation AnalysisThomas Røraas, Sverre Sandberg, Aasne K Aarsand, et al.
BMC Health Services Research|July 5, 2019
Self-efficacy and self-management strategies in acute intermittent porphyriaMarte H Hammersland, Aasne K Aarsand, Sverre Sandberg, et al.
Critical Reviews in Clinical Laboratory Sciences|May 17, 2022
Personalized reference intervals: from theory to practiceAbdurrahman Coskun, Sverre Sandberg, Ibrahim Unsal, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 28, 2024
Practical recommendations for biochemical and genetic diagnosis of the porphyriasAasne K Aarsand, Jordi To-Figueras, Sharon Whatley, et al.
Health and Quality of Life Outcomes|April 2, 2020
Health-related quality of life in porphyria cutanea tarda: a cross-sectional registry based studyJanice Andersen, Janne Thomsen, Åshild Rostad Enes, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|December 8, 2022
Frequency of JAK2V617F, MPL and CALR driver mutations and associated clinical characteristics in a Norwegian patient cohort with myeloproliferative neoplasmsSusanne Lilleskare, Marta Vorland, Anh Khoi Vo, et al.
Clinical Chemistry|August 26, 2024
Reference Intervals Revisited: A Novel Model for Population-Based Reference Intervals, Using a Small Sample Size and Biological Variation DataAbdurrahman Coşkun, Sverre Sandberg, Ibrahim Unsal, et al.
Pageof 7